Wandercraft today announced the acquisition of Ekso Bionics, Inc. from a subsidiary of ChronoScale Holdings Corporation (Nasdaq: CHRN), bringing together two leaders in robotic mobility. The two ...
Zacks Investment Research on MSN
Beta Bionics stock down despite iLet-Eversense 365 integration deal
Beta Bionics, Inc. BBNX recently announced a partnership with Senseonics SENS to expand compatibility between its automated ...
By bringing its first patch pump to market, Beta Bionics will be able to compete with industry leader Insulet.
The average one-year price target for Beta Bionics (NASDAQGM:BBNX) has been revised to $23.75 / share. This is an increase of 14.64% from the prior estimate of $20.72 dated September 11, 2026. These ...
Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that it plans to release its third quarter 2026 financial results ...
Expanded agreement with an existing AI infrastructure customer and new customer agreement increases contracted deployment pipeline and is expected to drive Company annualized revenue run rate to $1 ...
One day after FDA cleared its Mint patch pump, Beta Bionics priced a $150 million stock offering and cut 2026 revenue guidance. · 7 sources across the spectrum on IJR News.
Ekso Bionics stock faces a structural reset as its former public parent, ChronoScale Holdings, moves toward a planned ...
Beta Bionics investors should visit us at or call toll-free (833) 538-3601. Lawyers at Kahn Swick & Foti, LLC are available to dicuss your legal options. About the Lawsuit Beta Bionics and certain of ...
Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Beta Bionics, Inc. (“Beta Bionics” ...
Beta Bionics, Inc. ( BBNX) announced FDA clearance of Mint, its new patch pump featuring a reusable and disposable architecture, while unveiling 3D Intelligence, its next-generation insulin dosing ...
Beta Bionics is currently trading at $20.37, up from the previous close of $19.23 after opening at $18.70 on the Nasdaq. The stock has traded between $18.62 and $21.00 during the session, with trading ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results